Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-26

Clinical Trial Update: Human Mass Balance Study of Pyronaridine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating human mass balance of pyronaridine in malaria patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyronaridine (pyronaridine)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2022-01-26